About Lifesensors inc.
Founded in 1996, LifeSensors, Inc. is a global leader in research involving the Ubiquitin Proteasome System (UPS) a cellular pathway that degrades damaged proteins. LifeSensors pioneered the SUMO-fusion system for high quality protein expression. Development of cutting-edge tools for ubiquitin proteasome system (UPS) and Protein Targeting Chimers (PROTAC) is advancing the UPS field. Poly-ubiquitin affinity matrices, Tandem Ubiquitin Binding Entities (TUBES), are changing the way scientists make discoveries in UPS and identify novel biomarkers for neurodegeneration and drug discovery.
Biology & Business
Our R&D team is composed of highly experienced scientists who are leaders in protein expression and purification, protein chemistry, molecular biology, ubiquitin proteasome system enzyme assay development, novel and sensitive diagnostics systems, and drug discovery. Our leadership in these fields is highlighted in our patent and publication record, and our scientific team is interested in pursuing and developing innovative solutions to the UPS field.
Our business development team works with customers to develop customizable and cost-effective work plans. We seek to facilitate a smooth transfer of our technology, offering transfer and licensing terms that fit the needs of our client’s laboratory and organization for downstream commercialization development. Our sales and marketing managers possess in-depth product knowledge.
Corporate Management: Varsha Luthra, President and CEO
Varsha has held a number of positions in Software development companies. Most recently she was the head of LifeSensors HR Department. She is the founder of VLI Research Inc. A biotech company that launched applications of stable isotope labeled proteins, and had a major impact on solution based approaches to solving protein structures. VLI Research also marked several molecular biology products which advanced NMR based approaches to understanding protein structures.